Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. esp. enferm. dig ; 109(2): 91-105, feb. 2017. tab, ilus
Article in Spanish | IBECS | ID: ibc-159852

ABSTRACT

La manometría esofágica de alta resolución (MAR) está en fase de desarrollo, como se evidencia por las diferentes clasificaciones de Chicago. Con el fin de unificar criterios en algunos aspectos prácticos con limitada evidencia científica se llevó a cabo la Primera Reunión Nacional de Consenso en Manometría de Alta Resolución del Grupo Español de Motilidad Digestiva, en la que participaron un amplio grupo de expertos. Las propuestas se basaron en una encuesta previa con 47 preguntas, la exhaustiva revisión de la bibliografía disponible y la experiencia de los participantes. Se plantearon aspectos metodológicos sobre criterios de análisis poco definidos de algunos nuevos parámetros de alta resolución y otros aspectos no considerados, como la actividad espontánea o las ondas secundarias, elaborándose conclusiones finales con utilidad práctica (AU)


High resolution esophageal manometry (HRM) is currently under development as can be seen in the various Chicago classifications. In order to standardize criteria in certain practical aspects with limited scientific evidence, the First National Meeting for Consensus in High Resolution Manometry of the Spanish Digestive Motility Group took place, bringing together a wide group of experts. The proposals were based on a prior survey composed of 47 questions, an exhaustive review of the available literature and the experience of the participants. Methodological aspects relating to the poorly defined analysis criteria of certain new high resolution parameters were discussed, as well as other issues previously overlooked such as spontaneous activity or secondary waves. Final conclusions were drawn with practical application (AU)


Subject(s)
Humans , Male , Female , Manometry/instrumentation , Manometry/methods , Manometry , Consensus Development Conferences as Topic , Societies, Medical/organization & administration , Societies, Medical/standards , Anesthesia/trends , Anesthesia , Administration, Topical , Gastrointestinal Motility , Gastrointestinal Motility/physiology , Esophageal Motility Disorders/chemically induced , Esophageal Motility Disorders/complications , Muscle Contraction , Perfusion/methods
2.
Rev Esp Enferm Dig ; 109(2): 91-105, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27990836

ABSTRACT

High resolution esophageal manometry (HRM) is currently under development as can be seen in the various Chicago classifications. In order to standardize criteria in certain practical aspects with limited scientific evidence, the First National Meeting for Consensus in High Resolution Manometry of the Spanish Digestive Motility Group took place, bringing together a wide group of experts. The proposals were based on a prior survey composed of 47 questions, an exhaustive review of the available literature and the experience of the participants. Methodological aspects relating to the poorly defined analysis criteria of certain new high resolution parameters were discussed, as well as other issues previously overlooked such as spontaneous activity or secondary waves. Final conclusions were drawn with practical applications.


Subject(s)
Esophageal Diseases/diagnostic imaging , Esophagus/diagnostic imaging , Manometry/methods , Anesthesia , Consensus , Gastrointestinal Motility , Humans
3.
Case Rep Gastrointest Med ; 2015: 620374, 2015.
Article in English | MEDLINE | ID: mdl-26557393

ABSTRACT

Cicatricial pemphigoid (CP) is a rare blistering autoimmune disease. Esophageal involvement occurs in widespread disease and rarely appears as the only affected organ. We report a 67-year-old Caucasian female with esophageal dysphagia and weight loss. Several oral panendoscopies showed multiple exudative ulcerations with fibrin and webs in mid- and proximal esophagus and a peeling mucosa. There were no lesions in other organs. We established the diagnosis performing a direct immunofluorescence (DIF), demonstrating IgG3 and complement deposition along the basement membrane. As initial treatment the patient received prednisone 60 mg and 1 gr twice daily of mycophenolate mofetil (MMF) as a steroid-sparing agent due to its lower toxicity and its selective mechanism of action. Six months later there was a significant clinical improvement and the esophageal ulcerations had disappeared, developing cicatricial fibrous rings, although no stenosis was present. Four years later, the patient remains asymptomatic with a low maintenance dose of MMF.

4.
Gastroenterol. hepatol. (Ed. impr.) ; 32(6): 410-414, jun.-jul. 2009. ilus
Article in Spanish | IBECS | ID: ibc-60812

ABSTRACT

Los pacientes con mieloma múltiple (MM) no tienen mayor incidencia de pancreatitis aguda ni diferente etiología de ésta que la población general. Sin embargo, pueden presentar pancreatitis aguda, o hiperamilasemia o hiperlipasemia aisladas, por causas que son poco habituales sin la presencia de la enfermedad hematológica. En los pacientes con MM, la afectación hepática aparece en el 30 al 50% de los casos. Fundamentalmente se produce como infiltración difusa de predominio sinusoidal, y la aparición en forma de nódulos es menos frecuente. Se presenta el caso de un paciente que recibió un trasplante de médula ósea por MM y que presentó un cuadro compatible clínica y analíticamente con pancreatitis aguda de etiología no filiada, durante el que se identificó la presencia de múltiples lesiones hepáticas ocupantes de espacio que se diagnosticaron mediante biopsia como recidiva extramedular de mieloma (AU)


Patients with multiple myeloma (MM) do not have a higher incidence of acute pancreatitis or pancreatitis of other etiologies than the general population. However, these patients may develop acute pancreatitis, or hyperamylasemia or isolated hyperlipasemia, due to etiologies that are highly infrequent in the absence of hematological disease. Liver involvement is found in 30 50% of patients with MM and mainly manifests as diffuse sinusoidal infiltration and less frequently in the form of nodules. We report the case of a patient who underwent bone marrow transplantation due to MM who showed clinical and laboratory findings compatible with acute pancreatitis of unknown origin, during which the presence of multiple space-occupying hepatic lesions was identified. Based on the results of biopsy, a diagnosis of extramedullary recurrence of MM was established (AU)


Subject(s)
Humans , Male , Adult , Bone Marrow Transplantation/adverse effects , Pancreatitis, Acute Necrotizing/diagnosis , Liver Neoplasms/pathology , Multiple Myeloma/surgery , Recurrence
5.
Gastroenterol Hepatol ; 32(6): 410-4, 2009.
Article in Spanish | MEDLINE | ID: mdl-19500877

ABSTRACT

Patients with multiple myeloma (MM) do not have a higher incidence of acute pancreatitis or pancreatitis of other etiologies than the general population. However, these patients may develop acute pancreatitis, or hyperamylasemia or isolated hyperlipasemia, due to etiologies that are highly infrequent in the absence of hematological disease. Liver involvement is found in 30-50% of patients with MM and mainly manifests as diffuse sinusoidal infiltration and less frequently in the form of nodules. We report the case of a patient who underwent bone marrow transplantation due to MM who showed clinical and laboratory findings compatible with acute pancreatitis of unknown origin, during which the presence of multiple space-occupying hepatic lesions was identified. Based on the results of biopsy, a diagnosis of extramedullary recurrence of MM was established.


Subject(s)
Bone Marrow Transplantation , Liver Neoplasms/secondary , Multiple Myeloma/pathology , Multiple Myeloma/secondary , Pancreatitis/etiology , Postoperative Complications/diagnosis , Acute Disease , Adult , Amylases/blood , Humans , Lipase/blood , Liver Neoplasms/diagnostic imaging , Male , Multiple Myeloma/surgery , Pancreatitis/blood , Postoperative Complications/pathology , Tomography, X-Ray Computed , Transplantation, Autologous , Ultrasonography
6.
Int J Oncol ; 28(5): 1303-10, 2006 May.
Article in English | MEDLINE | ID: mdl-16596248

ABSTRACT

Several variables associated to thymidylate synthase (TS), the biological target of 5-fluorouracil (5FU) have been studied for their possible role as predictors of the clinical outcome and response to chemotherapy in colorectal cancer (CRC) patients. The level of protein expression and the number of variable tandem-repeats of a 28-bp sequence within the gene promoter have been proposed as predictive and/or prognostic factors with variable agreement, while consensus seems to be achieved with respect to the value of a single nucleotide polymorphism (SNP) described within this same region. More recently, an association between TS expression pattern and survival has been disclosed. Paraffin-embedded sections from 140 CRC patients were analyzed by immuno-histochemistry (Mab TS106) for TS levels and expression pattern. Also, VNTR and SNP were determined by polymerase-chain reaction (PCR) and restriction-length-fragment polymorphism (RFLP) in 123 and 112 patients, respectively. Cytoplasmic expression pattern tended to be associated to C SNP (p=0.06). Low TS expression levels, cytoplasmic expression pattern and C SNP arose as variables associated to longer progression-free survival (PFS) in patients treated with 5FU. Accordingly, patients having at least two favourable or unfavourable variables were classified respectively as 'low risk' and 'high risk', the former showing significantly longer PFS (p=0.0299). The possibility for designing a selection method for subsequent therapies is suggested on the basis of a probable combined effect of the above mentioned parameters but further studies in larger populations are needed to confirm these results.


Subject(s)
Colorectal Neoplasms/drug therapy , Fluorouracil/therapeutic use , Gene Expression Regulation, Neoplastic/drug effects , Polymorphism, Single Nucleotide , Thymidylate Synthase/genetics , Aged , Antimetabolites, Antineoplastic/therapeutic use , Colorectal Neoplasms/enzymology , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Disease-Free Survival , Female , Humans , Male , Middle Aged , Minisatellite Repeats , Neoplasm Staging , Polymorphism, Restriction Fragment Length , Survival Analysis , Thymidylate Synthase/antagonists & inhibitors , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...